Health Highlights: Nov. 7, 2022

Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more
Is surgery always necessary for chronic chest pain? A new clinical trial finds patients' overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more
Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more
Related Posts
Johnson & Johnson acepta un acuerdo de 8.9 mil millones de dólares en unas demandas por el polvo de talco
MIÉRCOLES, 5 de abril de 2023 (HealthDay News) -- Decenas de miles de personas...
¿Come mucho pescado? Su riesgo de melanoma podría aumentar
JUEVES, 9 de junio de 2022 (HealthDay News) -- Añadió pescado a su dieta para...
ASTRO: Shorter Radiation Feasible for Low-, Intermediate-Risk Prostate Cancer
MONDAY, Oct. 16, 2023 (HealthDay News) -- At five years, five-fraction...
What Causes Asthma? The 6 Most Common Causes
WEDNESDAY, May 10, 2023 (HealthDay News) -- Understanding what causes asthma can...